Table 1.
Clinical and biochemical characteristics of T2DM patients with and without PAD.
| T2DM patients without PAD | T2DM patients with PAD | P value | |
|---|---|---|---|
| N | 200 | 155 | |
| Age (years) | 57.38±10.71 | 57.82±9.91 | 0.696 |
| Gender (M/F) | 95/105 | 70/85 | 0.661 |
| Family history of T2DM n (%) | 10 (5.00%) | 7 (4.52%) | 0.832 |
| Duration of T2DM (years) | 8.58±3.43 | 11.39±2.86 | <0.001 |
| BMI (Kg/m2) | 25.41±3.84 | 25.14±3.72 | 0.510 |
| SBP (mmHg) | 144.62±25.91 | 148.48±22.97 | 0.145 |
| DBP (mmHg) | 86.21±14.54 | 84.87±13.54 | 0.376 |
| TC (mmol/L) | 5.14±1.15 | 5.42±1.27 | 0.031 |
| TG (mmol/L) | 1.87±0.60 | 1.92±0.59 | 0.783 |
| LDL-C (mmol/L) | 3.34±0.99 | 3.59±1.02 | 0.016 |
| HDL-C (mmol/L) | 1.28±0.34 | 1.28±0.28 | 0.946 |
| FPG (mmol/L) | 8.94±3.50 | 8.94±3.23 | 0.997 |
| P2PG (mmol/L) | 15.66±3.47 | 15.33±3.60 | 0.378 |
| HbA1c (%) | 9.34±2.24 | 9.20±2.13 | 0.563 |
| HOMA-IR | 3.63±0.70 | 4.37±0.89 | <0.001 |
| CRP (mg/L) | 2.35 (1.40–3.40) | 2.50 (1.50–4.40) | 0.108 |
| Nesfatin-1 (ng/mL) | 1.20 (0.96–1.36) | 0.91 (0.70–1.12) | <0.001 |
| ABI | 1.16±0.14 | 0.71±0.13 | <0.001 |